The SAVAL Trial
Details on the design and rationale behind this randomized trial studying infrapopliteal drug-eluting stent use for critical limb ischemia.
By Jihad A. Mustapha, MD, FACC, FSCAI; Patrick Geraghty, MD, FACS; and Hans van Overhagen, MD, PhD, EBIR